Also: The dangerous 'hidden' mental burden of cancer on patients' spousesAugust 19, 2024Check out STAT+Sponsored By Niki Chan Wylie for STAT STAT+ | AI drug firm Recursion seeks to move from survival to industry domination Recursion will release proof-of-concept clinical trial data over the next 12 months; investor interest in seeing if AI can speed drug development is high. By Allison DeAngelis 5 health issues to watch for at the Democratic National Convention Kamala Harris, Tim Walz, and other Democrats are likely to discuss reproductive rights, Medicaid, lower drug prices, and more at the DNC. By Sarah Owermohle STAT+ | Will the FTC challenge a deal that would give Novo Nordisk control of some Catalent plants? Will a complicated deal to buy a contract drugmaker clear FTC review? Novo target Catalent also makes some of Eli Lilly's best-selling drugs. By Ed Silverman Adobe Study exposes the dangerous 'hidden' mental burden of cancer on patients' spouses Risk of suicidal ideation was higher in the first year after a spouse's diagnosis, suggesting need for scrutiny and support. By Angus Chen STAT+ | Peter Orszag wants the FTC and DOJ to stop challenging 'vertical' health care mergers The Lazard CEO, one of the architects of the ACA, makes the case for vertical integration of health care, which reaps rewards for his firm. By Bob Herman Opinion: Private equity: health care's vampire Private equity companies should not be allowed to own hospitals, nursing homes, and physician practices. They are vampires on health care. By Steffie Woolhandler, David U. Himmelstein, Elizabeth Schrier, and Hope Schwartz John Lamparski/Getty Images for Concordia Summit STAT+ | Rick Doblin, 'unleashed,' blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy STAT interviews the psychedelic medicine pioneer on leaving the company he helped start and on the future of treating PTSD with MDMA. By Meghana Keshavan More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2024, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments